FDA 483 - Webster, Chad - November 28, 2023

An FDA inspection of Webster, Chad, a farm in Gilman, WI, revealed two significant issues. The firm was cited for extralabel drug use that resulted in a violative ampicillin residue in a cow, exceeding established safe levels. Additionally, the inspection found that the farm failed to maintain complete treatment records, lacking crucial details such as dosage, route of administration, and withdrawal periods.